An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes

Completed

Conditions studied: Eyelash Hypotrichosis

In brief

This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes.

Key facts

Study ID

NCT01623479

Run by

Allergan

People needed

585

Starts

2010-11-19

Expected to finish

2011-09-01

Last updated by the study team

2019-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Hypotrichosis of the eyelashes
• Using bimatoprost ophthalmic solution 0.03% (Latisse®) for at least 12 months

You may not qualify if…

• Use of any over-the-counter medication(s) for eyelash growth

Where it is running

• Study site — Santa Ana, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.